Serous tumors - general
Reviewer: Shahrzad Ehdaivand, M.D. (see Reviewers page)
Revised: 9 April 2013, last major update May 2012
Copyright: (c) 2003-2013, PathologyOutlines.com, Inc.
- 25% of all ovarian tumors
- 60% benign, 15% borderline, 30% malignant
- May also occur as primary tumors of peritoneal surface
- If cystic, name as serous "cystadeno..."
- If prominent fibrous component, name as adenofibroma or adenocarcinofibroma
- Tall, columnar, ciliated epithelial cells, resembling fallopian tube, filled with clear serous fluid
- Carcinomas frequently have psammoma bodies (concentric calcifications)
- Squamous metaplasia unlikely (in contrast to endometrioid tumors)
- CK7, CK8/18, CK19, EMA, B72.3, S100, amylase (25%), ER (50%), PR (50%), androgen receptor (50%), N-Cadherin
(Hum Pathol 1997;28:734)
- Usually CK7+ and CK20-
(Am J Clin Pathol 2002;117:944)
End of Ovary tumor > Serous tumors - general
This information is intended for physicians and related personnel, who understand that medical information is often imperfect, and must be interpreted in the context of a patient's clinical data using reasonable medical judgment. This website should not be used as a substitute for the advice of a licensed physician.
All information on this website is protected by copyright of PathologyOutlines.com, Inc. Information from third parties may also be protected by copyright. Please contact us at copyrightPathOut@gmail.com
with any questions (click here for other